Rosa Sousa
Overview
Explore the profile of Rosa Sousa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eberli D, Kranzbuhler B, Prause L, Baumgartner V, Preda S, Sousa R, et al.
J Cancer Res Clin Oncol
. 2022 Jun;
148(12):3351-3360.
PMID: 35751683
Background: Apalutamide (APA) is a next-generation androgen receptor antagonist for the treatment of advanced prostate cancer. We have previously shown that upregulation of autophagy is one of the mechanisms by...
2.
Kranzbuhler B, Sousa R, Prause L, Burger I, Rupp N, Sulser T, et al.
Cancer Rep (Hoboken)
. 2021 May;
4(6):e1418.
PMID: 34008909
Background: Dutasteride has been shown to increase expression of the prostate-specific membrane antigen (PSMA) in prostate cancer cells in previous in vitro studies. This 5-alpha-reductase inhibitor is commonly used for...
3.
Sousa R, Goncalves C, Guerra I, Costa E, Fernandes A, Sucesso M, et al.
Orphanet J Rare Dis
. 2016 Jul;
11(1):102.
PMID: 27456001
Background: Red cell distribution width (RDW), a classical parameter used in the differential diagnosis of anemia, has recently been recognized as a marker of chronic inflammation and high levels of...
4.
Couto D, Sousa R, Andrade L, Leander M, Lopez-Quintela M, Rivas J, et al.
Toxicol Lett
. 2015 Feb;
234(2):67-73.
PMID: 25683033
The use of iron oxide nanoparticles (ION) for diagnostic and therapeutic purposes requires a clear favorable risk-benefit ratio. This work was performed with the aim of studying the ability of...
5.
Gartner A, Pereira T, Simoes M, Armada-da-Silva P, Franca M, Sousa R, et al.
Neural Regen Res
. 2014 Dec;
7(29):2247-58.
PMID: 25538746
Many studies have been dedicated to the development of scaffolds for improving post-traumatic nerve regeneration. The goal of this study was to assess the effect on nerve regeneration, associating a...
6.
Sousa R, Ponte F, Teixeira S, Andrade L, Goncalves C, Barbot J, et al.
Mutat Res
. 2013 Apr;
754(1-2):58-62.
PMID: 23624100
Fanconi Anemia (FA) is a chromosome instability (CI) syndrome, clinically characterized by progressive bone marrow failure and increased cancer predisposition. Lymphocytes from FA patients have hypersensitivity to alkylating agents, particularly...
7.
Ponte F, Sousa R, Fernandes A, Goncalves C, Barbot J, Carvalho F, et al.
Orphanet J Rare Dis
. 2012 May;
7:28.
PMID: 22591656
Fanconi Anemia (FA) is a rare genetic disorder, characterized by progressive bone marrow failure and increased predisposition to cancer. Despite being highly heterogeneous, all FA patients are hypersensitive to alkylating...
8.
Gil da Costa R, Coelho P, Sousa R, Bastos M, Porto B, Teixeira J, et al.
Mutat Res
. 2012 May;
747(1):77-81.
PMID: 22565221
Ptaquiloside, a norsesquiterpene glycoside from bracken (Pteridium aquilinum), is a known carcinogen towards animals. Its genotoxicity is mainly attributed to its DNA-alkylating and clastogenic properties. This study analyses various modes...
9.
Porto B, Sousa R, Ponte F, Torgal A, Campilho F, Campos A, et al.
Acta Med Port
. 2011 Oct;
24(3):405-12.
PMID: 22015027
Fanconi Anemia (FA) is a rare recessive disorder clinically characterized by progressive bone marrow failure, diverse congenital malformations and increased predisposition to cancer. Given the late onset of anemia, relatively...